MATRIX SERVICE CO (MTRX)

US5768531056 - Common Stock

11.96  +0.22 (+1.87%)

After market: 11.96 0 (0%)

Fundamental Rating

4

Taking everything into account, MTRX scores 4 out of 10 in our fundamental rating. MTRX was compared to 41 industry peers in the Construction & Engineering industry. MTRX scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. MTRX has a decent growth rate and is not valued too expensively.



1

1. Profitability

1.1 Basic Checks

MTRX had negative earnings in the past year.
In the past year MTRX had a positive cash flow from operations.
MTRX had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: MTRX reported negative operating cash flow in multiple years.

1.2 Ratios

MTRX's Return On Assets of -4.71% is on the low side compared to the rest of the industry. MTRX is outperformed by 82.50% of its industry peers.
MTRX has a Return On Equity of -10.65%. This is amonst the worse of the industry: MTRX underperforms 80.00% of its industry peers.
Industry RankSector Rank
ROA -4.71%
ROE -10.65%
ROIC N/A
ROA(3y)-11.42%
ROA(5y)-7.25%
ROE(3y)-22.62%
ROE(5y)-14.13%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 5.43%, MTRX is doing worse than 80.00% of the companies in the same industry.
MTRX's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for MTRX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 5.43%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-25.27%
GM growth 5Y-14.38%

6

2. Health

2.1 Basic Checks

MTRX does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, MTRX has more shares outstanding
The number of shares outstanding for MTRX has been increased compared to 5 years ago.
MTRX has a better debt/assets ratio than last year.

2.2 Solvency

An Altman-Z score of 2.90 indicates that MTRX is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.90, MTRX perfoms like the industry average, outperforming 60.00% of the companies in the same industry.
There is no outstanding debt for MTRX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 2.9
ROIC/WACCN/A
WACC10.05%

2.3 Liquidity

A Current Ratio of 1.30 indicates that MTRX should not have too much problems paying its short term obligations.
With a Current ratio value of 1.30, MTRX perfoms like the industry average, outperforming 42.50% of the companies in the same industry.
MTRX has a Quick Ratio of 1.26. This is a normal value and indicates that MTRX is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.26, MTRX is in line with its industry, outperforming 47.50% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.3
Quick Ratio 1.26

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 53.63% over the past year.
Looking at the last year, MTRX shows a decrease in Revenue. The Revenue has decreased by -1.84% in the last year.
MTRX shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -6.14% yearly.
EPS 1Y (TTM)53.63%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q66.04%
Revenue 1Y (TTM)-1.84%
Revenue growth 3Y-10.28%
Revenue growth 5Y-6.14%
Revenue growth Q2Q-9.68%

3.2 Future

MTRX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 64.72% yearly.
Based on estimates for the next years, MTRX will show a quite strong growth in Revenue. The Revenue will grow by 10.17% on average per year.
EPS Next Y69.99%
EPS Next 2Y64.72%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1.54%
Revenue Next 2Y10.17%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MTRX. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 13.86 indicates a correct valuation of MTRX.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MTRX indicates a rather cheap valuation: MTRX is cheaper than 85.00% of the companies listed in the same industry.
MTRX is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 20.41, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 13.86

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, MTRX is valued cheaper than 82.50% of the companies in the same industry.
Industry RankSector Rank
P/FCF 15.16
EV/EBITDA N/A

4.3 Compensation for Growth

MTRX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as MTRX's earnings are expected to grow with 64.72% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y64.72%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for MTRX!.
Industry RankSector Rank
Dividend Yield N/A

MATRIX SERVICE CO

NASDAQ:MTRX (5/6/2024, 3:05:58 PM)

After market: 11.96 0 (0%)

11.96

+0.22 (+1.87%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap326.51M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 13.86
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.71%
ROE -10.65%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 5.43%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.89
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.3
Quick Ratio 1.26
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)53.63%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y69.99%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-1.84%
Revenue growth 3Y-10.28%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y